KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Enterprise Value: 2018-2025

Historic Enterprise Value for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $1.5 billion.

  • Twist Bioscience's Enterprise Value fell 38.15% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $687.3 million, marking a year-over-year decrease of 53.45%. This contributed to the annual value of $1.5 billion for FY2025, which is 38.15% down from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Enterprise Value is $1.5 billion, which was down 24.95% from $2.0 billion recorded in Q2 2025.
  • Twist Bioscience's 5-year Enterprise Value high stood at $6.0 billion for Q2 2021, and its period low was $469.8 million during Q1 2023.
  • For the 3-year period, Twist Bioscience's Enterprise Value averaged around $1.7 billion, with its median value being $1.8 billion (2023).
  • As far as peak fluctuations go, Twist Bioscience's Enterprise Value skyrocketed by 540.57% in 2021, and later crashed by 75.99% in 2022.
  • Twist Bioscience's Enterprise Value (Quarterly) stood at $3.5 billion in 2021, then slumped by 74.34% to $908.2 million in 2022, then soared by 99.82% to $1.8 billion in 2023, then spiked by 37.07% to $2.5 billion in 2024, then slumped by 38.15% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $2.0 billion for Q2 2025, and $2.1 billion during Q1 2025.